Cytek Biosciences (CTKB) EBT Margin (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly EBT Margin came in at 39.36% in Q1 2026, down 1219.0% YoY from 3.52% in Q1 2025, and down 506.82% on a QoQ basis from 6.49% in Q4 2025.
Cytek Biosciences (CTKB) EBT Margin (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of EBT Margin data on file, last reported at 39.36% in Q1 2026.
- Quarterly EBT Margin fell 1219.0% year-over-year to 39.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.61% (down 1356.0% YoY) and the FY2025 annual result came in at 14.81%, down 1197.0% from the prior year.
- EBT Margin declined to 39.36% in Q1 2026, from 6.49% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 17.96% in Q4 2024 to a low of 39.36% in Q1 2026.
- A 5-year average of 9.36% and a median of 9.42% in 2022 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2024 — EBT Margin surged 1090 bps — and 2025, when it plunged 2445 bps.
- Tracing CTKB's EBT Margin over 5 years: stood at 8.51% in 2022, then fell by 17 bps to 7.06% in 2023, then soared by 154 bps to 17.96% in 2024, then tumbled by 136 bps to 6.49% in 2025, then slumped by 507 bps to 39.36% in 2026.
- The last three EBT Margin figures came in at 39.36% (Q1 2026), 6.49% (Q4 2025), and 14.86% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 12.10% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.74% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 19.48% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.86% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.27% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.09% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.91% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 18.32% |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | -24.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.19% |
| Mar 31, 2026 | -39.36% |
| Dec 31, 2025 | -6.49% |
| Sep 30, 2025 | -14.86% |
| Jun 30, 2025 | -14.86% |
| Mar 31, 2025 | -27.18% |
| Dec 31, 2024 | 17.96% |
| Sep 30, 2024 | 0.30% |
| Jun 30, 2024 | -15.41% |
| Mar 31, 2024 | -20.05% |
| Dec 31, 2023 | 7.06% |
| Sep 30, 2023 | -8.72% |
| Jun 30, 2023 | -13.27% |
| Mar 31, 2023 | -24.37% |
| Dec 31, 2022 | 8.51% |
| Sep 30, 2022 | 4.57% |
| Jun 30, 2022 | -3.49% |
| Mar 31, 2022 | -9.42% |
| Dec 31, 2021 | 1.14% |
| Sep 30, 2021 | 6.04% |